Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Head and Neck Cancer

  Free Subscription


28.09.2026

1 Am J Pathol
1 Br J Cancer
1 Br J Oral Maxillofac Surg
2 Dis Esophagus
21 Head Neck
4 HNO
2 Int J Cancer
2 Int J Radiat Oncol Biol Phys
2 J Laryngol Otol
1 Oral Oncol
2 PLoS One
1 Radiology
3 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. BOYACK I, Berlied A, Lee SC, Campbell AA, et al
    MYC Is Functionally Required in Both Normal and Neoplastic Meibomian Glands.
    Am J Pathol. 2026;196:2223-2236.
    PubMed         Abstract available


    Br J Cancer

  2. BHOL CS, Kar RK, Mishra SR, Mishra P, et al
    PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.
    Br J Cancer. 2026 Sep 19. doi: 10.1038/s41416-026-03608.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  3. BOREWAD GD
    Comment on 'Lateralised pT3/T4N0 oral squamous cell carcinoma: is contralateral elective neck dissection or neck radiotherapy indicated? A multicentre retrospective study.
    Br J Oral Maxillofac Surg. 2026 Aug 30:S0266-4356(26)00226.
    PubMed        


    Dis Esophagus

  4. EDHOLM D, Kauppila JH, Achiam MP, Norholm Kempf O, et al
    Incidence of lymph node metastases in pT1 chemo- and radiotherapy-naive esophageal and gastric cancer in the Nordic countries: a retrospective multinational cohort analysis.
    Dis Esophagus. 2026;39:doag105.
    PubMed         Abstract available

  5. GROOTENHUIS JGA, Wijers S, Hannink G, Adbegovic I, et al
    Postoperative complications after Minimally Invasive transCervical oEsophagectomy (MICE) versus Transthoracic Minimally Invasive oEsophagectomy (TMIE): an inverse probability of treatment weighted analysis.
    Dis Esophagus. 2026;39:doag106.
    PubMed         Abstract available


    Head Neck

  6. LEVY BB, Wiercigroch J, Choudhary L, Shemesh-Lobl T, et al
    A Multimodal Analgesia Protocol to Reduce Opioid Use Following Oral Cavity Free Flap Reconstruction.
    Head Neck. 2026;48:2756-2763.
    PubMed         Abstract available

  7. HIRAI Y, Utsumi Y, Sano D, Kuwahara T, et al
    Establishment of Salivary Gland Tumors Arising in Salivary Gland-Specific EWSR1::ATF1 Transgenic Mice.
    Head Neck. 2026;48:2733-2744.
    PubMed         Abstract available

  8. DE RIDDER M, van de Velde LJ, de Bie T, van Noortwijk R, et al
    Predominance of In-Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single-Center Retrospective Study.
    Head Neck. 2026;48:2704-2712.
    PubMed         Abstract available

  9. D'ARCY SJ, Kennedy SL, Thomas JA, Rahman H, et al
    Calculating Glucagon-Like Pepide-1 Receptor Agonist-Associated Medullary Thyroid Cancer Risk: A Novel Integration of the Surveillance, Epidemiology and End Results Cancer Registry and the FDA Adverse Event Reporting System.
    Head Neck. 2026;48:2693-2703.
    PubMed         Abstract available

  10. SANCHEZ LP, Hintze J, Newman SK, Shaha A, et al
    Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm.
    Head Neck. 2026;48:2669-2676.
    PubMed         Abstract available

  11. PARTHA SARATHI CI, Alghnaimawi S, Naseem S, Shenton A, et al
    Evaluating the Clinical Impact of the Direct-To-Test Neck Lump Referral Pathway. A Retrospective Review at a District General Hospital.
    Head Neck. 2026;48:2677-2684.
    PubMed         Abstract available

  12. SANDA N, Sawabe M, Yamashita Y, Iwata H, et al
    Favorable Response to Intensity-Modulated Proton Therapy for Nasopharyngeal Non-Intestinal-Type Adenocarcinoma: A Case Report.
    Head Neck. 2026;48:E106-E111.
    PubMed         Abstract available

  13. KHAN S, Saini V, Singh V, Gulia A, et al
    Simultaneous Bi-Jaw Reconstruction: Double Free Fibula Flap Following Resection of Synchronous Oral Malignancy.
    Head Neck. 2026;48:E100-E105.
    PubMed         Abstract available

  14. TROKA ME, Gates JC
    Predicting Oral Cancer From Precursor Lesions: The Case for a Standardized Framework of Analysis to Improve Prediction Modeling.
    Head Neck. 2026 Sep 24. doi: 10.1002/hed.70465.
    PubMed         Abstract available

  15. ASHJI G, Rajan A, Dahl E, Ramanan S, et al
    Predictors of Delayed and Omitted Postoperative Radiotherapy After Laryngectomy for pT4 Laryngeal Cancer.
    Head Neck. 2026 Sep 21. doi: 10.1002/hed.70482.
    PubMed         Abstract available

  16. ZHAO D, Wan M, Xu X, Huang Z, et al
    Toripalimab Plus TPF as Induction Chemoimmunotherapy for the Treatment of Locally Advanced Hypopharyngeal Carcinoma: A Prospective Phase II Study.
    Head Neck. 2026 Sep 21. doi: 10.1002/hed.70417.
    PubMed         Abstract available

  17. USHIRO K, Takahashi D, Yamashita R, Mizuno K, et al
    Predicting Occult Retropharyngeal Lymph Node Metastasis in Surgically Treated Oropharyngeal and Hypopharyngeal Carcinoma: An Integrated Clinico-Radiological Model.
    Head Neck. 2026 Sep 20. doi: 10.1002/hed.70486.
    PubMed         Abstract available

  18. LIN MC, Jiang X, Qiu ZC, Zhou X, et al
    Management of the Clinically Node-Negative Neck in Intermediate-Grade Mucoepidermoid Carcinoma of the Head and Neck: A Single-Institution Retrospective Study.
    Head Neck. 2026;48:2773-2781.
    PubMed         Abstract available

  19. BELLAVANCE S, Khoury M, Colivas J, Primiani J, et al
    Comparison of In-Office and General Anesthesia Biopsies for Oropharyngeal Squamous Cell Carcinoma in a Public Healthcare System.
    Head Neck. 2026;48:2792-2799.
    PubMed         Abstract available

  20. JACKERT EP, Koh M, Vimawala S, Tang L, et al
    Swab-Derived Viral Load as a Biomarker of Tumor Biology in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Head Neck. 2026;48:2782-2791.
    PubMed         Abstract available

  21. SURENDRAN S, Sunny SP, Chathoth PM, Magner WJ, et al
    Pattern of Progression of Oral Potentially Malignant Disorders From Real-World Data: A 24-Year Study.
    Head Neck. 2026;48:2800-2809.
    PubMed         Abstract available

  22. DEGRANGE M, Morisseau M, Michel J, Reverdy T, et al
    Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study.
    Head Neck. 2026;48:2810-2820.
    PubMed         Abstract available

  23. KWAN MM, Bazzi LA, Sun Z, Rand D, et al
    Impact of Smoking on Treatment Outcomes in Patients With Human Papillomavirus-Related Oropharyngeal Cancer.
    Head Neck. 2026;48:2821-2829.
    PubMed         Abstract available

  24. TRUONG AA, Ho S, Lee RH, Wu X, et al
    Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer.
    Head Neck. 2026;48:2863-2870.
    PubMed         Abstract available

  25. WU FY, Ko HH, Kao HF, Cheng SJ, et al
    Incidence and Site-Specific Risk Factors of Jaw Osteoradionecrosis for Head and Neck Patients in the IMRT/VMAT Era: Evidence From a Large, Hospital-Based Cohort.
    Head Neck. 2026;48:2883-2892.
    PubMed         Abstract available

  26. AITA M, Galofaro I, Maniaci A, Lechien JR, et al
    Survival Outcomes of Head and Neck Neuroendocrine Carcinoma: A Systematic Review.
    Head Neck. 2026;48:2901-2921.
    PubMed         Abstract available


    HNO

  27. GONCALVES M, Knopf A, Hackenberg S
    [Surgical trials in head and neck cancer at the 2026 ASCO Annual Meeting].
    HNO. 2026 Sep 23. doi: 10.1007/s00106-026-01807.
    PubMed         Abstract available

  28. SAUTER C, Laban S, Hoffmann TK, Zenk J, et al
    [The 9th edition of the UICC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery].
    HNO. 2026;74:673-677.
    PubMed         Abstract available

  29. QUAAS A, Lyu SI
    [Intraoperative pathology in head and neck tumors].
    HNO. 2026;74:647-652.
    PubMed         Abstract available

  30. RINK M, Symeou L, Mansour N, Ettl T, et al
    [Current German S3 guideline on salivary gland tumors from an otolaryngological perspective].
    HNO. 2026;74:712-720.
    PubMed         Abstract available


    Int J Cancer

  31. VAN DER ZIJDEN CJ, Huizer TJ, Eyck BM, van der Gaast A, et al
    Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: TNT-OES-1 Trial.
    Int J Cancer. 2026;159:2552-2561.
    PubMed         Abstract available

  32. QUAAS A, Schiemann H, Lyu SI, Zander T, et al
    Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.
    Int J Cancer. 2026 Aug 12. doi: 10.1002/ijc.70687.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  33. LEE PY, Lee PH, Tu HF, Liao TL, et al
    Palbociclib Enhances Radiation Therapy Efficacy by Promoting Apoptosis and Immune Modulation in Oral Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2026;126:834-847.
    PubMed         Abstract available

  34. YIP PL, Chua MLK
    Induction Chemotherapy in Nasopharyngeal Carcinoma: Is More Necessarily Better?
    Int J Radiat Oncol Biol Phys. 2026;126:805-807.
    PubMed        


    J Laryngol Otol

  35. YOSEFOF E, Zavdy O, Coreanu T, Kurman N, et al
    Axillary metastases following total laryngectomy: an under-recognised pathway.
    J Laryngol Otol. 2026;140:896-902.
    PubMed         Abstract available

  36. KANG YJ, Kim MS, Park YS, Cho JH, et al
    Primary angiosarcoma of the nasal septum: a rare case report and literature review.
    J Laryngol Otol. 2026;140:918-922.
    PubMed         Abstract available


    Oral Oncol

  37. PATEL AN, Wu SS, Colevas AD, Divi V, et al
    Estimated costs of intravenous vs subcutaneous pembrolizumab in perioperative head and neck cancer: subcutaneous administration is unlikely to reduce costs.
    Oral Oncol. 2026;182:108125.
    PubMed        


    PLoS One

  38. INADA J, Minabe M, Akiyama Y, Higa K, et al
    Two opposite effects of desmoglein 3 on the growth of oral squamous cell carcinoma between anchorage -dependent and -independent conditions.
    PLoS One. 2026;21:e0358339.
    PubMed         Abstract available

  39. DING J, Hu X, Sun M, Ge S, et al
    Associations of the metabolic score for insulin resistance and uric acid with prevalent thyroid nodules: A cross-sectional study with systolic blood pressure mediation analysis and C-TIRADS category-specific analyses.
    PLoS One. 2026;21:e0358879.
    PubMed         Abstract available


    Radiology

  40. SUH PS, Kim J, Kim DE, Han K, et al
    Reliability and Validity of Imaging-derived Extranodal Extension Grading Using CT and MRI in Nasopharyngeal Carcinoma.
    Radiology. 2026;320:e260053.
    PubMed         Abstract available


    Radiother Oncol

  41. ALY F, Descallar J, Robledo K, Sundaresan P, et al
    External validation of a head & neck cancer outcome prediction model in radiotherapy patients: Evaluating generalisability in a geographically diverse population, with particular consideration of older patients.
    Radiother Oncol. 2026;223:111714.
    PubMed         Abstract available

  42. CHEN X, Huang Y, Lin K, Chen J, et al
    De-escalating elective nodal irradiation dose to 45?Gy in nasopharyngeal carcinoma: A large-cohort study with 5-year outcomes.
    Radiother Oncol. 2026 Sep 25:111795. doi: 10.1016/j.radonc.2026.111795.
    PubMed         Abstract available

  43. VAN KEEKEN K, Badiu V, Vilches-Freixas G, Buijsen J, et al
    Impact of accumulated target dose on tumor response in distal esophageal cancer treated with intensity-modulated proton therapy.
    Radiother Oncol. 2026;225:111788.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum